✕
NEWS
Home
NEWS
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
All
MauriceHampsink
27 juni 2022
27 juni 2022
Xenikos Enrolls First Patient in Global Pivotal Phase 3 Study Evaluating T-Guard® in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
8 september 2021
8 september 2021
Xenikos Secures €40 Million in Convertible Debt Financing, Veloxis Pharmaceuticals Joins as Strategic Investor
19 juli 2021
19 juli 2021
Xenikos Announces T-Guard Phase 3 Clinical Update and Outlines 2021-2022 Corporate Objectives
Load more